Trainer Julie Miller thinks three could be a charm in the $500,000 Yonkers Trot on Saturday night at Yonkers Raceway. Miller’s trio of trainees, Devious Man, Money Macintosh and Top Flight Angel, compose one third of the nine-horse field of 3-year-old colt and gelding trotters. “I’m happy with the position I’m in,” Miller said. “Of...
NYS Entity Status
NYS Filing Date
OCTOBER 10, 2013
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2013 - NORWICH YONKERS LLC
AROUND THE WEB
- Devious Man one to beat in Yonkers Trot
By tholmlundnyp - Saturday Sep 2, 2017
- Hall of Fame rider enjoys historic night at Yonkers
By Debbie Little - Saturday Sep 2, 2017
With more than 9,800 wins in his Hall of Fame career driver, Brian Sears has pretty much done it all. Until Saturday night at Yonkers Raceway that is, where he did something for the first time, winning two Triple Crown races on the same night. Sears won both the $500,000 Yonkers Trot with Top Flight...
- Recalling Spygate wreckage, the original NY-Boston scandal
By Mark Cannizzaro - Wednesday Sep 6, 2017
Ten years ago “Spygate’’ consumed the NFL with a news cycle it wished never got started. It wrecked relationships, cost the Patriots draft picks and money, and forever tarnished the reputation of the franchise and its Hall of Fame-bound head coach, Bill Belichick. Eric Mangini, then the Jets coach, blew the whistle on the Patriots...
- Women of Sex Tech, Unite
By ANNA NORTH - Friday Aug 18, 2017
New York is becoming a cultural center for young women trying to disrupt the male-dominated industries of design engineering and sex toys.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.
- IFM Gets $300M Bristol Buyout, Plans Second Strike With New Spinout
By Ben Fidler - Thursday Aug 3, 2017
Bristol-Myers Squibb this afternoon is acquiring a young startup, IFM Therapeutics, in an unusual deal that will also see the big drugmaker get a chance to own rights in a new company the biotech is spinning out as well. New York-based Bristol (NYSE: BMY) will pay $300 million up front for IFM, which will give […]